Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
1 min & # 3 min charts & L2 suggest prob go a bit higher today, however no volume in last 1.5 hrs for daytraders..longer term is a HUGE upside trading at basically it's 2.5 year low! I'd snag and hold as a 100% is coming from its current level.
I like the histogram and MACD...candles--so so..volume low.watch for a late day pull or AM..i'd prob lock in profits here based on the chart
SBFM spank that ASK and let's go!!
SBFM spank that ASK and let's go!!
Yes ma'am! :)
I try ma'am! True ladies are #1 in my heart!!! oh, and you're marked!!
Outstanding!!! $$$ and fun!!!
And I meant fellas...and MOST importantly LADIES!!
Thanks and I'm very grateful for all the kindness shown!!
Thank you ma'am!! Obviously need to put more pictures and such!! Not my skill set! Lol
Thanks for this!!!
Early Merry Christmas friends!!!!
Cool site!! Marked!
nice forum!! marked
Awesome site!! Marked
Fellas!!
BPAX Strong RECENT history above $2.00
Date Open High Low Close Volume Adj
Close
2011/12/21 0.42 0.51 0.40 0.45 14,676,700 0.45
2011/12/20 0.40 0.43 0.39 0.42 9,079,027 0.42
2011/12/19 0.45 0.47 0.38 0.38 12,004,546 0.38
2011/12/16 0.50 0.50 0.43 0.45 11,769,238 0.45
2011/12/15 0.47 0.54 0.46 0.48 49,749,291 0.48
2011/12/14 2.50 2.65 2.02 2.12 11,369,459 2.12
2011/12/13 2.56 2.66 2.51 2.52 2,104,723 2.52
2011/12/12 2.42 2.55 2.40 2.54 1,947,689 2.54
2011/12/09 2.40 2.46 2.32 2.45 2,034,602 2.45
2011/12/08 2.47 2.51 2.35 2.35 1,710,081 2.35
2011/12/07 2.52 2.52 2.43 2.45 1,267,873 2.45
2011/12/06 2.57 2.60 2.50 2.56 1,522,545 2.56
2011/12/05 2.56 2.62 2.51 2.56 1,349,389 2.56
2011/12/02 2.54 2.58 2.49 2.52 1,906,027 2.52
2011/12/01 2.42 2.52 2.40 2.48 2,146,817 2.48
2011/11/30 2.40 2.43 2.33 2.40 2,002,268 2.40
2011/11/29 2.35 2.45 2.32 2.32 1,450,679 2.32
2011/11/28 2.36 2.40 2.22 2.32 2,044,920 2.32
2011/11/25 2.26 2.32 2.22 2.22 573,262 2.22
2011/11/24 2.33 2.33 2.25 2.25 1,291,037 2.25
2011/11/23 2.33 2.34 2.25 2.25 1,291,037 2.25
2011/11/22 2.40 2.45 2.31 2.34 1,189,078 2.34
2011/11/21 2.33 2.41 2.24 2.37 1,979,800 2.37
2011/11/18 2.49 2.50 2.35 2.35 2,894,454 2.35
2011/11/17 2.54 2.55 2.41 2.50 1,634,993 2.50
2011/11/16 2.45 2.65 2.40 2.52 4,788,005 2.52
2011/11/15 2.48 2.48 2.30 2.34 3,482,169 2.34
2011/11/14 2.37 2.44 2.32 2.41 2,063,893 2.41
2011/11/11 2.39 2.42 2.35 2.37 1,186,241 2.37
2011/11/10 2.52 2.52 2.35 2.37 1,925,126 2.37
2011/11/09 2.48 2.60 2.44 2.48 1,390,823 2.48
2011/11/08 2.53 2.63 2.50 2.52 1,447,441 2.52
2011/11/07 2.58 2.61 2.45 2.50 1,534,240 2.50
2011/11/04 2.59 2.65 2.55 2.56 1,234,690 2.56
2011/11/03 2.65 2.70 2.55 2.62 1,154,373 2.62
2011/11/02 2.57 2.68 2.52 2.63 1,319,282 2.63
2011/11/01 2.55 2.59 2.45 2.51 1,715,333 2.51
2011/10/31 2.70 2.73 2.58 2.65 1,349,754 2.65
2011/10/28 2.68 2.76 2.58 2.75 1,466,407 2.75
2011/10/27 2.60 2.70 2.58 2.69 1,900,676 2.69
2011/10/26 2.50 2.59 2.47 2.54 2,102,416 2.54
2011/10/25 2.58 2.60 2.44 2.44 1,769,597 2.44
2011/10/24 2.35 2.56 2.35 2.56 2,823,986 2.56
2011/10/21 2.42 2.42 2.32 2.35 1,316,926 2.35
2011/10/20 2.41 2.43 2.32 2.36 980,601 2.36
2011/10/19 2.49 2.49 2.37 2.38 1,468,886 2.38
2011/10/18 2.38 2.48 2.30 2.42 1,482,189 2.42
2011/10/17 2.50 2.53 2.35 2.37 1,009,656 2.37
2011/10/14 2.49 2.53 2.42 2.51 1,026,826 2.51
2011/10/13 2.34 2.48 2.33 2.47 1,117,301 2.47
2011/10/12 2.37 2.40 2.32 2.34 1,055,081 2.34
2011/10/11 2.42 2.49 2.33 2.35 1,909,057 2.35
2011/10/10 2.31 2.36 2.27 2.34 717,465 2.34
2011/10/07 2.39 2.40 2.26 2.27 1,182,893 2.27
2011/10/06 2.29 2.40 2.20 2.38 1,064,862 2.38
2011/10/05 2.30 2.35 2.21 2.29 1,442,502 2.29
2011/10/04 2.07 2.32 2.02 2.31 2,569,058 2.31
2011/10/03 2.25 2.28 2.01 2.02 2,879,686 2.02
2011/09/30 2.29 2.36 2.25 2.28 1,197,343 2.28
2011/09/29 2.44 2.48 2.26 2.33 1,985,512 2.33
2011/09/28 2.53 2.55 2.37 2.37 2,049,561 2.37
2011/09/27 2.47 2.55 2.44 2.53 2,085,345 2.53
2011/09/26 2.49 2.50 2.41 2.42 1,335,235 2.42
2011/09/23 2.38 2.55 2.37 2.45 1,839,401 2.45
2011/09/22 2.50 2.54 2.38 2.42 3,267,004 2.42
2011/09/21 2.74 2.77 2.60 2.60 1,458,393 2.60
2011/09/20 2.82 2.85 2.72 2.73 1,900,234 2.73
2011/09/19 2.68 2.84 2.67 2.80 1,751,795 2.80
2011/09/16 2.75 2.77 2.67 2.74 2,146,580 2.74
2011/09/15 2.84 2.84 2.72 2.74 1,968,918 2.74
2011/09/14 2.83 2.85 2.75 2.80 2,308,170 2.80
2011/09/13 2.80 2.83 2.70 2.77 2,097,063 2.77
2011/09/12 2.81 2.90 2.70 2.77 2,479,437 2.77
2011/09/09 2.88 2.93 2.70 2.75 3,187,950 2.75
2011/09/08 2.61 2.92 2.58 2.89 4,858,013 2.89
2011/09/07 2.61 2.69 2.56 2.63 2,523,746 2.63
2011/09/06 2.41 2.55 2.40 2.55 1,373,576 2.55
2011/09/05 2.46 2.52 2.46 2.52 1,870,185 2.52
2011/09/02 2.46 2.58 2.42 2.52 1,869,685 2.52
2011/09/01 2.65 2.71 2.55 2.57 2,552,606 2.57
2011/08/31 2.76 2.80 2.60 2.62 3,757,588 2.62
2011/08/30 2.59 2.68 2.52 2.68 2,199,126 2.68
2011/08/29 2.40 2.63 2.40 2.61 2,859,360 2.61
2011/08/26 2.31 2.37 2.25 2.36 1,214,982 2.36
2011/08/25 2.43 2.48 2.30 2.34 1,133,982 2.34
2011/08/24 2.40 2.48 2.35 2.42 1,759,156 2.42
2011/08/23 2.40 2.41 2.26 2.41 1,718,858 2.41
2011/08/22 2.37 2.42 2.24 2.30 2,070,722 2.30
2011/08/19 2.28 2.43 2.20 2.22 3,270,997 2.22
2011/08/18 2.50 2.50 2.31 2.35 3,126,871 2.35
2011/08/17 2.73 2.82 2.59 2.64 2,158,507 2.64
2011/08/16 2.60 2.70 2.53 2.67 2,556,040 2.67
2011/08/15 2.57 2.75 2.54 2.65 3,811,121 2.65
2011/08/12 2.33 2.52 2.31 2.48 2,838,221 2.48
2011/08/11 2.30 2.40 2.21 2.27 3,416,363 2.27
2011/08/10 2.29 2.31 2.15 2.17 3,384,870 2.17
2011/08/09 2.29 2.42 2.15 2.31 4,856,428 2.31
2011/08/08 2.13 2.34 2.02 2.06 4,829,240 2.06
2011/08/05 2.35 2.62 2.15 2.37 5,241,197 2.37
2011/08/04 2.68 2.68 2.19 2.22 7,328,216 2.22
thanks! trying to find a "worthy" pic!!!
LQMT .145 X .15 +16.2%..see if it bounces back to .18
LQMTDAYTRADE as it moves past .13 look for test of .145 and .189 previous high..
LQMT watch as a day trade...just had RSI 10 bust the 30 line. MACD also crossed. If it moves past .13 watch for a test of .145 .164 and .189 previous high
LQMT watch as a day trade...just has RSI 10 bust the 30 line. MACD also crossed. If it moves past .13 watch for a test of .145 .164 and .189 previous high
.21 let's move today!!
ZERO .36 X .37 +8.7% already!! Candles are BULLISH !!
SBFM .21 lets move baby!!
Nice!!
I'm gonna spend more time finding pics to post on your site rather than stock analysis!!
hmmmm..prob the Pics and a tight second are the Picks!!
I think I LOVE this board!!
No kidding! This baby moves soon!!!
SBFM A little Christmas Volume will move it!!
SBFM A little Christmas Volume will move it!!
Signs Point to Economy’s Rise, but Economists Don't Agree
Full Story: http://www.cnbc.com/id/45763062
Merck (MRK) gains Approval for HiV Medication
Health care shares are higher in late-session trading while Merck & Co. (MRK) gets a key approval for one of its HIV medications.
The U.S. Food and Drug Administration approved an expanded label for MRK's HIV treatment that is used in conjunction with other antiretroviral drugs in children.
VNRX (PR) New Patent Filed
VolitionRX Limited (VNRX.OB), a life sciences company focused on developing blood-based diagnostic tests, is pleased to announce that it has filed a further patent application building on its Nucleosomics technology platform.
VolitionRX has developed methods to detect nucleosome adducts of cancer origin which are circulating in the blood of cancer patients and has filed a patent application covering both the use of these adducts as biomarkers and the methods for their detection. The new patent application, "Method For Detecting Nucleosome Adducts" [US 61/568,090] was filed on December 7, 2011. The existence of these nucleosome adducts was previously unknown.
Jake Micallef, Chief Scientific Officer of Belgian Volition says, "We have high hopes that these advances will find application in the diagnosis of certain cancers, particularly cancers whose growth is steroid dependent."
Cameron Reynolds, CEO of VolitionRX says, "Our scientific team is carrying out work on two Nucleosomics fronts at present: continuing internal validations of our technology on blood samples from cancer and non-cancer patients; and finding other novel applications for Nucleosomics. We are very excited that our team has discovered another promising potential diagnostic application from our Nucleosomics patent estate."
About VolitionRX
VolitionRX is a life sciences company whose goal is to make its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests on similar formats.
VolitionRX is managed by a well-respected team with extensive experience in diagnostics and commercialization. VolitionRX's development activities are currently centered in Belgium and will be augmented by commercialization work in Singapore with a focus on bringing its revolutionary diagnostic products to market first in Europe, then the U.S. and worldwide.
VolitionRX is quoted on the OTC Bulletin Board in the United States of America, under the symbol VNRX.OB.
Forward-Looking Statements: Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "optimizing," "potential," "goal," and similar expressions, as they relate to the Company, its business or management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's filings with the Securities and Exchange Commission.
TheBullEconomist forum is here and ready to explode!!